Category: FDA & Regulatory Policy

June 7, 2021

Alliance for Aging Research’s Statement on FDA Decision to Approve Alzheimer’s Treatment

Alliance for Aging Research President and CEO Sue Peschin, MHS, released the following statement in response to the FDA’s decision…
November 17, 2020

Alliance for Aging Research Submits Feedback to the FDA on Draft Geriatric Labeling Guidance

On November 16 , the Alliance for Aging Research submitted feedback to the Food and Drug Administration (FDA) on its…
November 12, 2020

Alliance for Aging Research Provides Comment on Medical Device User Fee Amendments

On October 27, 2020, the Alliance for Aging Research’s Michael Ward provided public comment to the U.S. Food and Drug…
November 12, 2020

Alliance for Aging Research Submits Feedback to the Centers for Medicare and Medicaid Services on Medicare Coverage for Innovative Technology

On Monday, November 2, the Alliance for Aging Research submitted feedback to the Centers for Medicare and Medicaid Services (CMS)…
September 21, 2020

National Groups Call on U.S. Federal Health Agency Leaders to Stand Strong for Science Over Politics in the Fight Against COVID-19

The Alliance for Aging Research (Alliance) and 78 other national organizations representing patients, healthcare providers, and multi-stakeholder coalitions…
August 21, 2020

Alliance for Aging Research Submits Comments on Reauthorization of the Prescription Drug User Fee Act

      On Friday, August 21, the Alliance for Aging Research submitted feedback to the U.S. Food and…
February 12, 2020

Alliance for Aging Research Statement on FY2021 White House Proposed Budget

WASHINGTON, February 12, 2020 – The Alliance for Aging Research’s (Alliance) President and CEO Susan Peschin, MHS, has released the…
December 21, 2019

Alliance for Aging Research Statement on the FY2020 Budget

WASHINGTON, December 21, 2019 – The Alliance for Aging Research’s (Alliance) President and CEO Susan Peschin, MHS, has released the…
December 13, 2019

Alliance for Aging Research Congratulates Dr. Stephen Hahn on Appointment to FDA Commissioner

      Yesterday the Senate confirmed Dr. Stephen Hahn as the Commissioner of the U.S. Food and Drug…
November 19, 2019

Alliance for Aging Research Supports the Nomination of Dr. Stephen Hahn for FDA Commissioner

On November 18, Alliance for Aging Research President and CEO Sue Peschin, MHS, sent a letter to the Senate on…